⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Molly MandernachM.D.

Hematology · Gainesville, FL 32610

NPI: 1912088063

Share:

42

🟠 Elevated

Risk Flags

Extreme opioid rate vs specialty peers99th percentile opioid prescribingHigh long-acting opioid rate vs peers

Risk indicators are statistical patterns, not allegations. Learn more

171

Total Claims

$56K

Drug Cost

20

Beneficiaries

$2,812

Cost/Patient

Risk Score Breakdown 42/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid rate vs specialty peers+25
Opioid rate (national percentile)+9
Long-acting opioid rate+8

Score components are additive. Read full methodology

Peer Comparison vs. 775 Hematology providers

+1243%

Opioid rate vs peers

68.4% vs 5.1% avg

-84%

Cost per patient vs peers

$2,812 vs $18K avg

+16%

Brand preference vs peers

26.9% vs 23.1% avg

⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.

🔎 Data Overview

⚠️

Opioid prescribing rate is 1,243% above the average for Hematology providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

68.4%

Opioid Rate

117

Opioid Claims

$38K

Opioid Cost

51.3%

Long-Acting Rate

This provider's opioid prescribing rate of 68.4% is above the 20% threshold that CMS considers elevated.

Brand vs Generic

73% generic

Brand: 46 claims · $49K

Generic: 125 claims · $7,602

Patient Profile

54

Avg Age

Female

4.69

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About